{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:46:47Z","timestamp":1785876407026,"version":"3.56.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402347"],"award-info":[{"award-number":["82402347"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012548","name":"Heilongjiang Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["LBH-Z23029"],"award-info":[{"award-number":["LBH-Z23029"]}],"id":[{"id":"10.13039\/100012548","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014418","name":"Harbin Medical University Cancer Hospital","doi-asserted-by":"publisher","award":["JJZD2024-27"],"award-info":[{"award-number":["JJZD2024-27"]}],"id":[{"id":"10.13039\/100014418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515140069"],"award-info":[{"award-number":["2024A1515140069"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M740945"],"award-info":[{"award-number":["2023M740945"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.biomaterials.2026.124387","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:44:45Z","timestamp":1781624685000},"page":"124387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Legumain-activated radio-immunological synergist potentiates the abscopal effect via dual CD47\/PD-L1 blockade and macrophage repolarization"],"prefix":"10.1016","volume":"335","author":[{"given":"Yingtao","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuofeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwen","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmei","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1919-1145","authenticated-orcid":false,"given":"Jiaqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3560-4432","authenticated-orcid":false,"given":"Hong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2026.124387_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(19)30792-2","article-title":"Attrition in metastatic breast cancer: a metric to be reported in randomised clinical trials?","volume":"21","author":"Nuzzolese","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biomaterials.2026.124387_bib2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.mattod.2025.01.009","article-title":"Chemotherapeutics-enabled apoptosis-pyroptosis switch to trigger adaptive and innate immunity for metastatic breast cancer immunotherapy","volume":"83","author":"Zhong","year":"2025","journal-title":"Mater. Today"},{"key":"10.1016\/j.biomaterials.2026.124387_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12943-024-02165-x","article-title":"Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124387_bib4","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrclinonc.2012.194","article-title":"Image-guided radiotherapy: from current concept to future perspectives","volume":"9","author":"Jaffray","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124387_bib5","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/j.apsb.2024.03.022","article-title":"Engineering nanomedicines for immunogenic eradication of cancer cells: recent trends and synergistic approaches","volume":"14","author":"Elzoghby","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biomaterials.2026.124387_bib6","doi-asserted-by":"crossref","first-page":"14848","DOI":"10.1021\/acsnano.4c18627","article-title":"A metformin-based multifunctional nanoplatform as a DNA damage amplifier for maximized radio-immunotherapy to overcome radiotherapy resistance","volume":"19","author":"He","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124387_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202419418","article-title":"A PD-L1 siRNA-loaded boron nanoparticle for targeted cancer radiotherapy and immunotherapy","volume":"37","author":"Deng","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124387_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202501077","article-title":"Biomimetic engineering of hybrid radiosensitizers to boost radiotherapy against cancer metastasis","volume":"37","author":"Xiang","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124387_bib9","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJMoa1112824","article-title":"Immunologic correlates of the abscopal effect in a patient with melanoma","volume":"366","author":"Postow","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2026.124387_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.currproblcancer.2015.10.001","article-title":"Systematic review of case reports on the abscopal effect","volume":"40","author":"Abuodeh","year":"2016","journal-title":"Curr. Probl. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124387_bib11","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41591-018-0232-2","article-title":"Radiotherapy induces responses of lung cancer to CTLA-4 blockade","volume":"24","author":"Formenti","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2026.124387_bib12","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/s41467-023-37328-9","article-title":"STING agonist-loaded, CD47\/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124387_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202211332","article-title":"Reprogramming hypoxic tumor-associated macrophages by nanoglycoclusters for boosted cancer immunotherapy","volume":"35","author":"Zhao","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124387_bib14","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrc.2016.54","article-title":"The role of myeloid cells in cancer therapies","volume":"16","author":"Engblom","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124387_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122474","article-title":"Arginine-assembly as NO nano-donor prevents the negative feedback of macrophage repolarization by mitochondrial dysfunction for cancer immunotherapy","volume":"306","author":"Zheng","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2026.124387_bib16","article-title":"Novel photo-STING agonists delivered by erythrocyte efferocytosis-mimicking pattern to repolarize tumor-associated macrophages for boosting anticancer immunotherapy","volume":"36","author":"Li","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124387_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.123028","article-title":"Emerging nanomedicines for macrophage-mediated cancer therapy","volume":"316","author":"Shi","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2026.124387_bib18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41577-024-01080-y","article-title":"Inducible antibacterial responses in macrophages","volume":"25","author":"Sweet","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124387_bib19","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","article-title":"Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biomaterials.2026.124387_bib20","doi-asserted-by":"crossref","first-page":"27804","DOI":"10.1021\/acsnano.5c08928","article-title":"Noninvasive activation of local and systemic immunity with a sequential-targeting sonodynamic nanovaccine to treat glioblastoma","volume":"19","author":"Cheng","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124387_bib21","doi-asserted-by":"crossref","first-page":"5653","DOI":"10.1038\/s41467-023-41438-9","article-title":"Cell microparticles loaded with tumor antigen and resiquimod reprogram tumor-associated macrophages and promote stem-like CD8+ T cells to boost anti-PD-1 therapy","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124387_bib22","doi-asserted-by":"crossref","first-page":"16056","DOI":"10.1021\/acsnano.3c04778","article-title":"Chimeric peptide engineered bioregulator for metastatic tumor immunotherapy through macrophage polarization and phagocytosis restoration","volume":"17","author":"Chen","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124387_bib23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41392-025-02178-y","article-title":"Deep insight into cytokine storm: from pathogenesis to treatment","volume":"10","author":"Nie","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biomaterials.2026.124387_bib24","doi-asserted-by":"crossref","first-page":"16222","DOI":"10.1021\/acs.jmedchem.4c00804","article-title":"Discovery and evaluation of TLR-targeted immune agonists","volume":"67","author":"Chernyak","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biomaterials.2026.124387_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012500","article-title":"Where does ISAC (immune- stimulating antibody conjugates) go from here?","volume":"13","author":"Fu","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124387_bib26","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s43018-022-00456-0","article-title":"Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect","volume":"3","author":"Nishiga","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124387_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl9330","article-title":"ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer","volume":"7","author":"Hsieh","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124387_bib28","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1038\/s41467-020-18245-7","article-title":"Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells","volume":"11","author":"Candas-Green","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124387_bib29","doi-asserted-by":"crossref","first-page":"16770","DOI":"10.1021\/acsnano.3c03456","article-title":"Sequential targeting hybrid nanovesicles composed of chimeric antigen receptor T-cell-derived exosomes and liposomes for enhanced cancer immunochemotherapy","volume":"17","author":"Zhu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124387_bib30","article-title":"Reengineering the tumor oxygen microenvironment in radiotherapy to enhance T-cell function for radio-immunotherapy","volume":"35","author":"Chen","year":"2025","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2026.124387_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303835","article-title":"Extracellular vesicles-derived hybrid nanoplatforms for amplified CD47 blockade-based cancer immunotherapy","volume":"35","author":"Tang","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124387_bib32","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jconrel.2024.07.039","article-title":"A polymeric nanoplatform enhances the cGAS-STING pathway in macrophages to potentiate phagocytosis for cancer immunotherapy","volume":"373","author":"Li","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biomaterials.2026.124387_bib33","article-title":"Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis","volume":"363","author":"Xu","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.biomaterials.2026.124387_bib34","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41590-023-01671-2","article-title":"CD47 masks pro-phagocytic ligands in cis on tumor cells to suppress antitumor immunity","volume":"24","author":"Tang","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124387_bib35","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","article-title":"Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance","volume":"16","author":"Martins","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124387_bib36","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/S1470-2045(18)30828-3","article-title":"New therapeutic perspectives to manage refractory immune checkpoint-related toxicities","volume":"20","author":"Martins","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biomaterials.2026.124387_bib37","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1021\/acsnano.3c10862","article-title":"A twindrive precise delivery system of platelet-neutrophil hybrid membrane regulates macrophage combined with CD47 blocking for postoperative immunotherapy","volume":"18","author":"Sheng","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124387_bib38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1021\/acsnano.3c05829","article-title":"In situ nanofiber patch boosts postoperative hepatocellular carcinoma immune activation by trimodal combination therapy","volume":"18","author":"Zhao","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124387_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114308","article-title":"Local scaffold-assisted delivery of immunotherapeutic agents for improved cancer immunotherapy","volume":"185","author":"Shang","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2026.124387_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1774615","article-title":"Role of innate immunity in the development of cancer immunotherapy immune-mediated adverse events","volume":"17","author":"Sierra-Salazar","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124387_bib41","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1158\/1078-0432.CCR-18-2795","article-title":"Circulating cytokines predict immune-related toxicity in melanoma patients receiving anti-PD-1-based immunotherapy","volume":"25","author":"Lim","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biomaterials.2026.124387_bib42","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1038\/s41467-025-57965-6","article-title":"A protease-cleavable liposome for co-delivery of anti-PD-L1 and doxorubicin for colon cancer therapy in mice","volume":"16","author":"Liu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124387_bib43","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1021\/acsnano.3c05882","article-title":"Radioresponsive delivery of toll-like receptor 7\/8 agonist for tumor radioimmunotherapy enabled by core-cross-linked diselenide nanoparticles","volume":"18","author":"Wu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124387_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adq3940","article-title":"Tumor-specific delivery of clickable inhibitor for PD-L1 degradation and mitigating resistance of radioimmunotherapy","volume":"10","author":"Hou","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biomaterials.2026.124387_bib45","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1038\/s41467-026-70858-6","article-title":"CXCR5+ monocyte emigration impairs the radiation-induced antitumor immune response","volume":"17","author":"Lei","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124387_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122392","article-title":"Self-reinforced photodynamic immunostimulator to downregulate and block PD-L1 for metastatic breast cancer treatment","volume":"303","author":"Qiu","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2026.124387_bib47","article-title":"Pyroptosis-inducing self-adaptor to potentiate immune checkpoint blockade therapy for breast cancer by reeducating the treatment-recruited macrophages","volume":"35","author":"Qiu","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2026.124387_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2024.109846","article-title":"Nutrients deprivation of biomimetic nanozymes for cascade catalysis triggered and oxidative damage induced tumor eradication","volume":"36","author":"Zhong","year":"2025","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.biomaterials.2026.124387_bib49","doi-asserted-by":"crossref","first-page":"172","DOI":"10.7150\/ijbs.36467","article-title":"Legumain promotes gastric cancer progression through tumor-associated macrophages in vitro and in vivo","volume":"16","author":"Wang","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biomaterials.2026.124387_bib50","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1021\/ja307083b","article-title":"Functional imaging of legumain in cancer using a new quenched activity-based probe","volume":"135","author":"Edgington","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2026.124387_bib51","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jconrel.2024.05.022","article-title":"Radiation-primed TGF-\u03b2 trapping by engineered extracellular vesicles for targeted glioblastoma therapy","volume":"370","author":"Liang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biomaterials.2026.124387_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101244","article-title":"Recombinant cancer nanovaccine for targeting tumor-associated macrophage and remodeling tumor microenvironment","volume":"40","author":"Tang","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.biomaterials.2026.124387_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202313097","article-title":"Dismantlable coronated nanoparticles for coupling the induction and perception of immunogenic cell death","volume":"36","author":"Liang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124387_bib54","article-title":"Biomimetic nano-degrader based CD47-SIRP\u03b1 immune checkpoint inhibition promotes macrophage efferocytosis for cardiac repair","volume":"11","author":"Gao","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biomaterials.2026.124387_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202415078","article-title":"Plasma membrane targeted photodynamic nanoagonist to potentiate immune checkpoint blockade therapy by initiating tumor cell pyroptosis and depleting infiltrating B cells","volume":"37","author":"Zhong","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124387_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202312026","article-title":"Physicochemical targeting of lipid nanoparticles to the lungs induces clotting: mechanisms and solutions","volume":"36","author":"Omo\u2010Lamai","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124387_bib57","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1039\/D5MH01048A","article-title":"Lymph node-targeted metabolic regulatory nanovaccines to boost cancer immunotherapy by potentiating dendritic cell-mediated antigen presentation","volume":"12","author":"Zhong","year":"2025","journal-title":"Mater. Horiz."},{"key":"10.1016\/j.biomaterials.2026.124387_bib58","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.scib.2018.05.028","article-title":"Identification and functional analysis of heterogeneous FOXP3+ Treg cell subpopulations in human pancreatic ductal adenocarcinoma","volume":"63","author":"Yi","year":"2018","journal-title":"Sci. Bull."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226004114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226004114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:04:04Z","timestamp":1785873844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226004114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":58,"alternative-id":["S0142961226004114"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124387","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Legumain-activated radio-immunological synergist potentiates the abscopal effect via dual CD47\/PD-L1 blockade and macrophage repolarization","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124387"}}